The U.S. Food and Drug Administration has approved ALung’s Investigational Device Exemption, allowing the HemoLung Respiratory Assist System to be used in a clinical study in order to collect safety and effectiveness data.
The U.S. Food and Drug Administration has approved ALung’s Investigational Device Exemption, allowing the HemoLung Respiratory Assist System to be used in a clinical study in order to collect safety and effectiveness data.